BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Prasad KT, Kaur H, Muthu V, Aggarwal AN, Behera D, Singh N. Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients. World J Clin Oncol 2018; 9(7): 140-147 [PMID: 30425939 DOI: 10.5306/wjco.v9.i7.140]
URL: https://www.wjgnet.com/2218-4333/full/v9/i7/140.htm
Number Citing Articles
1
Foteinos-Ioannis Dimitrakopoulos, Achilleas Nikolakopoulos, Anastasia Kottorou, Fotini Kalofonou, Elias Liolis, Theodora Frantzi, Ioannis Pyrousis, Angelos Koutras, Thomas Makatsoris, Haralabos Kalofonos. PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) InhibitorsCancers 2020; 12(5): 1257 doi: 10.3390/cancers12051257
2
Giuseppe A. Colloca, Antonella Venturino. Prognostic Effect of Performance Status on Outcomes of Patients with Colorectal Cancer Receiving First-Line Chemotherapy: A Meta-analysisJournal of Gastrointestinal Cancer 2023;  doi: 10.1007/s12029-023-00983-8
3
Kuruswamy Thurai Prasad, Valliappan Muthu, Bivas Biswas, Prabhat Singh Malik, Deepak Dabkara, Sandip Ganguly, Joydeep Ghosh, Babita Kataria, Sachin Khurana, Saurav Verma, Navneet Singh. Utility and safety of maintenance chemotherapy in advanced non–small cell lung cancer across various performance status categories: real-world experienceCurrent Problems in Cancer 2020; 44(3): 100565 doi: 10.1016/j.currproblcancer.2020.100565
4
Pralhad Adhikari, Suzanne McLaren. Functional Impairment and Depressive Symptoms among Older Adults of Rural Nepal: The Moderating Role of Three Sources of Social SupportClinical Gerontologist 2023; 46(5): 832 doi: 10.1080/07317115.2023.2187732
5
Giuseppe Colloca. Performance status as prognostic factor in phase III trials of first‐line chemotherapy of unresectable or metastatic pancreatic cancer: A trial‐level meta‐analysisAsia-Pacific Journal of Clinical Oncology 2022; 18(3): 232 doi: 10.1111/ajco.13598
6
Marcela Cortés-Jofré, Rolando Uranga, Ania Torres Pombert, Maria del Carmen Arango Prado, Iraida Caballero Aguirrechu, Cecilia Pacheco, Rosa Maria Ortiz Reyes, Fernando Chuecas, Pedro Inocente Mas Bermejo. Therapeutic vaccines for advanced non-small cell lung cancerCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD013377
7
Ankan Bandyopadhyay, Siddharth Sharma, Digambar Behera, Navneet Singh. UGT1A1 Gene Polymorphisms in Patients with Small Cell Lung Cancer Treated with Irinotecan-Platinum Doublet Chemotherapy and Their Association with Gastrointestinal Toxicity and Overall SurvivalThe Oncologist 2021; 26(8): 701 doi: 10.1002/onco.13757
8
Yueying Li, Yajun Chen, Yaqi Zeng, Jie Dong, Chunlei Li, Yingjie Jia, Yonghua Zhao, Kun Wang, Yoshiki Mukudai. Enteral Nutrition Combined with Improved-Sijunzi Decoction Shows Positive Effect in Precachexia Cancer Patients: A Retrospective AnalysisEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/7357521
9
Marcela Cortés-Jofré, Mikel Rueda-Etxebarria, Emeline Orillard, Elena Jimenez Tejero, José-Ramón Rueda. Therapeutic vaccines for advanced non-small cell lung cancerCochrane Database of Systematic Reviews 2024; 2024(3) doi: 10.1002/14651858.CD013377.pub2
10
Christen R. Elledge, Anna W. LaVigne, Jacob Fiksel, Jean L. Wright, Todd McNutt, Lawrence R. Kleinberg, Chen Hu, Thomas J. Smith, Scott Zeger, Theodore L. DeWeese, Sara R. Alcorn. External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone MetastasesJCO Clinical Cancer Informatics 2021; (5): 304 doi: 10.1200/CCI.20.00128
11
Aynur Aktas, Milena Macedo Couto, Declan Walsh. We report performance status in oncology—but not nutritional status?Supportive Care in Cancer 2020; 28(12): 5605 doi: 10.1007/s00520-020-05689-2
12
Gaurav Garg, Kuruswamy Thurai Prasad, Navneet Singh, Parul Gupta, Valliappan Muthu, Ashim Das, Amanjit Bal. Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parametersJournal of Pathology and Translational Medicine 2021; 55(6): 398 doi: 10.4132/jptm.2021.08.08
13
Foteinos-Ioannis Dimitrakopoulos, Giannis Mountzios, Petros Christopoulos, Thomas Papastergiou, Mariam Elshiaty, Lea Daniello, Elefterios Zervas, Sofia Agelaki, Epaminondas Samantas, Adamantia Nikolaidi, Ilias Athanasiadis, Sofia Baka, Konstantinos Syrigos, Athina Christopoulou, Evangelos Lianos, Konstantinos Samitas, Nikolaos Tsoukalas, Eleni-Isidora Perdikouri, George Oikonomopoulos, Anastasia Kottorou, Foteini Kalofonou, Thomas Makatsoris, Angelos Koutras, Vasileios Megalooikonomou, Haralabos Kalofonos. Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre studyTherapeutic Advances in Medical Oncology 2022; 14: 175883592211227 doi: 10.1177/17588359221122728
14
Kurt G. Tournoy, Valerie Adam, Inge Muylle, Helene De Rijck, Ellen Everaert, Ehsan Eqlimi, Jan P. van Meerbeeck, Piet Vercauter. Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology PatientsCancers 2023; 15(15): 3821 doi: 10.3390/cancers15153821